Monday 4 April 2016

RE-Sosei Group Corp/Ralph Acampora/Apr 2016



Sosei Group Corp (Jp:4565)Date-of-Incorporation
1990-6-22
Chinese Bazi Astro--There could be some monthly "fortune" by say Apr 7
年柱食神庚午正印
月柱偏財壬午正印
日柱日主戊午正印

2016 Apr 7--偏財壬辰比肩流月

Godfather’ of chart analysis says the stock-market correction is over--Rebound will keep happening for commodities, emerging markets, says Ralph Acampora
(http://www.marketwatch.com/story/godfather-of-chart-analysis-says-the-stock-market-correction-is-over-2016-03-30?Link=obnetwork)

Background
Sosei Group Corporation is a holding company primarily engaged in the biopharmaceutical business. The Company is mainly involved in the research, development and sale of pharmaceutical drugs, including NVA237 and QVA149, used for chronic obstructive pulmonary disease; SO - 1105, used for oral thrush. As of March 31, 2013, the Company had three consolidated subsidiaries
(http://www.reuters.com/finance/stocks/companyProfile?symbol=4565.T)

No comments: